tirzepatide trial results (Zepbound; Eli Lilly and Co) demonstrated 47% greater relative weight loss compared to semaglutide (Wegovy; Novo Nordisk) in the SURMOUNT-5 phase 3b open-label trial. Full will be presented at a Results of the phase 3b

Unlike stimulants or over-the-counter supplements, it works with the bodys natural hormones to regulate hunger and blood sugar

Yet others have to purchase new wardrobes or alter their appetites, anything but simple

GLP-1 Is a Tool, Not a Shortcut Its important to understand that GLP-1 medications are not a replacement for healthy habits

I would not recommend them if you: Are currently pregnant or breastfeeding Have a known active cancer diagnosis (especially hormone-sensitive cancers) Are on immunosuppressive therapy without coordination with your specialist Have a history of severe allergic reactions to peptide-based medications As with all treatments, personalized guidance matters